Delivery Order SPE2DX22D0089-SPE2D825F2A67
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,917.58 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is performed at the contractor's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,779.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 21, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,088.64 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 16, 2025, with an ultimate completion date of July 17, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The awardee, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $22,324.37 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The contract was performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,489.46 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 23, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,256.94 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 24, 2025, with completion expected by June 25, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,637.54 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award carries no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,710.34 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 9, 2025, with an ultimate completion date of June 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate...
- SPE2DX22D0089Indefinite Delivery Contract
- SPE2DX22D0089-SPE2D825F2A67Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $15,695.61 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs for military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp maintains a comprehensive Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical through December 2026 (contract SPE2DX), which serves as the prime vehicle enabling this delivery order. Through this global pharmaceutical support contract, the company supplies a wide range of products including brand-name and generic medications, vaccines, specialty pharmaceuticals, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its capability to meet rigorous federal procurement requirements and serve diverse government healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 6/2/25 |